Abstract
Foot infections, being one of the major complications, account for nearly 15% of people with diabetes, and increase their risk for amputation in lower extremities. Though various factors contribute to the development of diabetic foot infection, poor glycemic control poses a greater risk paving the way for a number of micro-organisms to colonize the wound.
In order to restore the lost granulation tissue at the ulcer site, the prime aim should not only be attaining glycemic control but also must focus on performing culture by clinically differentiating the stage of infection as well as to manage or control the infection by selecting a rational empiric antibiotic regimen, amidst the uncertainty that exists in choosing best antimicrobial therapy in emerging multi-drug resistance worldwide. This review mainly analyzes that although among the existence of various undefined microbiome being prevalent in causing diabetic foot infections, how the current trend of antibiotics in use aids in treating foot infections in diabetes.Keywords: Diabetic foot infections, matrix metallo-proteinases, wagner classification, methicillin resistant Staphylococcusaureus, antimicrobial therapy, microbiome.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:A Review on the Current Principles of Antibiotic Therapy for Diabetic Foot Infection
Volume: 21 Issue: 5
Author(s): Sainath Prasanna Bharathi and Sathesh Kumar Sukumaran*
Affiliation:
- School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai 600117, Tamilnadu,India
Keywords: Diabetic foot infections, matrix metallo-proteinases, wagner classification, methicillin resistant Staphylococcusaureus, antimicrobial therapy, microbiome.
Abstract:
Foot infections, being one of the major complications, account for nearly 15% of people with diabetes, and increase their risk for amputation in lower extremities. Though various factors contribute to the development of diabetic foot infection, poor glycemic control poses a greater risk paving the way for a number of micro-organisms to colonize the wound.
In order to restore the lost granulation tissue at the ulcer site, the prime aim should not only be attaining glycemic control but also must focus on performing culture by clinically differentiating the stage of infection as well as to manage or control the infection by selecting a rational empiric antibiotic regimen, amidst the uncertainty that exists in choosing best antimicrobial therapy in emerging multi-drug resistance worldwide. This review mainly analyzes that although among the existence of various undefined microbiome being prevalent in causing diabetic foot infections, how the current trend of antibiotics in use aids in treating foot infections in diabetes.Export Options
About this article
Cite this article as:
Bharathi Prasanna Sainath and Sukumaran Kumar Sathesh *, A Review on the Current Principles of Antibiotic Therapy for Diabetic Foot Infection, Infectious Disorders - Drug Targets 2021; 21 (5) : e270421188440 . https://dx.doi.org/10.2174/1871526520999201126203738
DOI https://dx.doi.org/10.2174/1871526520999201126203738 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adipocytokines; Cause for Metabolic Syndrome
Current Medicinal Chemistry - Central Nervous System Agents Cardiovascular Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Subject Index To Volume 2
Current Rheumatology Reviews Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges
Current Drug Safety Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?
Current Pharmaceutical Biotechnology Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Are Bacteriocins Underexploited? NOVEL Applications for OLD Antimicrobials
Current Pharmaceutical Biotechnology Relaxin, Insulin and Diabetes: An Intriguing Connection
Current Diabetes Reviews Intradialytic Hypertension: An Under-recognized Cardiovascular Risk Factor. What is the Evidence?
Current Hypertension Reviews Markers of Early Vascular Ageing
Current Pharmaceutical Design Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke
Current Cardiology Reviews Vitamins in the Prevention or Delay of Cognitive Disability of Aging
Current Aging Science Cocoa Polyphenols: Evidence from Epidemiological Studies
Current Pharmaceutical Design Statins in Bacteremia, Sepsis and Pneumonia: Have We Found the Holy Grail?
Recent Patents on Inflammation & Allergy Drug Discovery Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Potential Replication of Induced Pluripotent Stem Cells for Craniofacial Reconstruction
Current Stem Cell Research & Therapy The Role of P2Y<sub>12</sub> Receptor and Activated Platelets During Inflammation
Current Drug Targets The Roles of Cytochrome P450 in Ischemic Heart Disease
Current Drug Metabolism Pathophysiological Roles of Nitric Oxide: In the Heart and the Coronary Vasculature
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets